What is LBRX's cash ratio?

LBRX (LBRX) reported cash ratio of 29.4× in Q1 2026.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

LBRX LBRX Cash ratio

Cash ratio at other companies

Bristol-Myers SquibbBMY

0.5×0.0×

AlkermesALKS

0.6×-0.3×

MapLight Therapeutics, Inc. MPLT

3.9×—

Alto NeuroscienceANRO

20.1×-2.1×

Zevra Therapeutics, Inc.ZVRA

2×+0.6×

Opko HealthOPK

0.2×-0.3×

Other financials

Income statement

See full

Net income-$19.1M-259%

EPS (diluted)-$0.67+95.5%

Balance sheet

See full

Cash & equivalents$320.7M—

Total debt$3.5M—

Total equity$378.7M+481%

Total assets$393.5M—

Cash flow

See full

Operating cash flow-$23.3M-187%

CapEx$32.0K+52.4%

Free cash flow-$23.3M-186%

Valuation

See full

Market cap$874.06M+159%

Enterprise value$556.86M—

Returns & leverage

See full

Return on equity-27.9%—

Debt / equity0×—

Current ratio35.7×—

Where this comes from

Calculated from LBRX’s reported figures.

cash and equivalents/total current liabilities=29.4×

Based on the most recent quarter.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LBRX's cash ratio?: LBRX (LBRX) reported cash ratio of 29.4× in Q1 2026.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.